Institutional members access full text with Ovid®

Share this article on:

Efficacy of Combination Vedolizumab and Ustekinumab for Refractory Crohn's Disease

Huff-Hardy, Kayci MD, PhD*; Bedair, Mai BS, MPH; Vazquez, Rebecca MD; Burstein, Ezra MD, PhD*

Inflammatory Bowel Diseases: October 2017 - Volume 23 - Issue 10 - p E49
doi: 10.1097/MIB.0000000000001232
Online Only: Letters to the Editor
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website